FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience

BACKGROUND: FOLFIRINOX has been shown to significantly increase both overall survival (OS) and progression-free survival (PFS) in metastatic pancreas cancer. There is limited data regarding the treatment of locally advanced pancreatic cancer. We present a retrospective study of patients with both lo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Chllamma, Muralidharan K, Cook, Natalie, Dhani, Neesha C, Giby, Kazim, Dodd, Anna, Wang, Lisa, Hedley, David W, Moore, Malcolm J, Knox, Jennifer J
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2016
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5023770/
https://ncbi.nlm.nih.gov/pubmed/27467054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.222
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky